Vectus Biosystems: Could this drug eventually prevent thousands of deaths?
Listen to ASX-listed Vectus Biosystems CEO Karen Duggan talk to Matt Birney on the Bulls N’ Bears Report about Vectus’ rapidly developing treatment for a condition that is a factor in up to 40 per cent of all deaths.

Larvotto Resources: Gold, antimony, tungsten – and now copper! Larvotto takes out ASX junior.
03:16

Pacgold: QLD assets vended with upside and SA gold production underway
03:01

Koonenberry Gold: It's one of them – an historic gold-copper project with geological goodies everywhere!
03:08